Влияние предшественника лей-энкефалина на активность ферментов обмена регуляторных пептидов головного мозга и периферических органов крыс в норме и при эмоционально-болевом стрессе

Hooper N.M. Anзiotensin converting enzyme implications from molecular biology for its physiological functions // Int. J. Biochem. - 1991. - V.23. - N.7-8. - P.641-647.

Hooper N.M., Turner A.J. Isolation of two differentially glycosylated from of peptide-dipeptidases A (ACE) from pig brain: a reevaluation of teiner role in neuropeptide-metabolism // Biochem. 1987.-241, №15.-P.1455-1463

Hughes J., Smith T.W., Kosterlitz H. Wetal Identification of two related pentapeptides from the brain with potent opiate agonist activity // Nature. - 1975. - V.258. - N.5536. - P.577-579.

Hui K.-S., Lajlha A. Neuropeptidases / Handbook of Neurochemistry. - New York and London, 1983. - V.4. - P.1-19.

I'Hereault S., Barden N. Regulation of proopiomelanocortin messenger RNA - concentrations by opioid peptides in primary all cultures of rat hypotalamus // Mol. Brain. Res. 1991. - 10 (2). - P.115-121.

Jankovic B.D., Radulovic I. Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity // Int. J. Neurosci. - 1992, Nov-Dec. - V.67. - N.1-4. - P.241-270.

Jiang Z.G., North R.A. Pre- and postsynaptic inhibition by opioids in rat striatum // J. Neurosci. - 1992, Jan. - V.12. - N.1. - P.356-361.

Junkinz G. Changes of pain threshold aften stress-possible involvement of endogenous opiates // Arzeneimittel Forscheeng Drug. Res. - 1980. - V.30-2. N.8. - P.1237-1238.

Kastin A.Y., Nissen C., Coy D.H. DSIP - like immunoreactivity in the developing rat brain // Brain. Res. Bull. - 1981. - 7. - P.687-690.

Khanna A.S., Waisman D.M. Metabolism and intracellular processing of protein hormones /Hormones and their actions. Part 1. / Eds. B.A.Cooke et al. - Amsterdam, 1988. - P.117-132.

Khawaja X.Z., Green J.C., Thorpe J.R. The occurence and receptor specificy of endogenous opioid peptides within the pancreas and liver of the rat / Comporison with brain // J. Biochim.-1990.-Apr.1.- 267, №1.P. 233-240

Kramer T.H., Toth G., Haaseth R.C., Matsunage T.O., Davis P., Hruby V.I., Burks T.F. Influence of peptidase inhibitors on the apparent agonist potency of delta celective opioid peptides in vitro // Life Sci. - 1991. - V.48. - N.9. - P.881-6.

Krieger D.T. Brain peptides: what, where and why? // Science. - 1983. - V.222. - N.462. - P.975-985.

Lansillo J.J., Stevens J., Dazaratty Y., Yotsumoto H., Fanburg B.L. Angiotensin-converting enzyme from human tessues, physicochemical, catalitic and immunological properties // J. Biol. Chem. - 1985. - V.260. - N.28. - P.14938-14944.

Lantz I., Thornwall M., Kihlstrom J.E., Nyberg F. A comparison of human lung, brain, CSF and plasma angiotensin-converting enzyme with regard to neuropeptide metabolism // Biochem. Int. - 1992, Mar. - V.26. - N.3. - P.415-426.

Lanzillo J.J., Stevens J., Dararatty Y. et.al. Angiotensin-converting enzyme from human tessues, physicochemical, catalic and immunological properties // J. Biol. Chem.-1985.-260, №28.-P.14938-14944

Ling N., Burdus R., Guillemin R. Isolation primary structure and synthesis of б-endorphin and г-endorphin, two peptides of hypothalamic hypophysial origin with morphinomimetic activity // Proc. Nat. Acad. Sci. USA. - 1976. - V.73. - P.3942-3943.

Loe K.S., Frank S., Vanderklish P. Et al. Inhibitions of proteolisis protect hyppocampal neurons from ischemia // Proc. Nat. Acad. Sci. USA. - 1991. - V.88. - N.16. - P.7233-7237.

Loh Y.P., Birch N.P., Castro M.G. Pro-opiomelanocortin and provasopressin converting enzyme in pituitary secretory vesicles // Biochemie.-1988.-70, №1.-P.11-16

Loh M.H.., Theng L.F., Wei E., Li C.H. в-endorphin as a potent analgetic agent /Proc. Nat. Acad. Sci. USA. - 1976. - V.73. - N.8. - P.2895-2898.

Lynch D.R., Snyder S.H. Neuropeptides. Multiple molecular forms. Metabolic pathways and receptors // Anme. Rev. Biochem.-55.- Calif.Alto.-1986.- P.773-799

Lynch D.R., Vanable J.C., Snyder S.H. Enkephalin convertase in the heart similar disposition to atrial natriuretic factor // Endocrinology.- 122, № 6.- P.2683-2691

Mains R.E., Eipper B.A. Secretion and regulation of two biosyntetic enzyme activities, peptidil-glycine б-amidating monooxygenase and a carboxypeptidase, by mouse pituitary corticotropic tumor cells // Endocrinology.- 1984.-115, №5.-P.1683-1690

Makara G.B., Palrovits M., Szentagothai J. The endocrine hypothalamus and the hormonal response to stress /Selyes guide to stress research. / Selye H. (eds.). - New York: Van Nostrand Reinhold Co. - 1980. - P.280-337.

McDomald J.K., Schwabe C. Intracellular exopeptidases /Proteinases in Mammalian Cells and Tissues / Barrett A.I. (eds.). - Amsterdam: Elsevier /North Holland Biomedical Press. - 1977. - P.311-391.

Mentein R., Roos T. Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells // Peptides. - 1996. - V.17. - N.4. - P.709-720.

Meunier J.C. The opiad peptides and their receptors // Biochemie.- 1986.-68.- P.1153-1158

Millan M.J., Emrich H.M. Endorphinegric system and the response to stress //Psychother. Psychosomat. - 1981. - V.36. - N.1. - P.43-56.

Mulder A.H., Wardeh G., Hogenbom F., Frankhuyzen A.L. Selectivity of various opioid peptides toward delta-kappa-and mu-opioid receptors mediating presinaptic inhibition of neurotransmitter release in the brain // Neuropeptides.- 1989.-Aug-Sep.-14, №2.- P.99-104

Nakamura M., Kamata R., Jnour H., Inaba M. Effects of opioid peptides administration in conscious rats on the changes in blood adrenaline levels caused by immobilization stress // Jap. J. Pharmacol. - 1989. - V.50. - N.3. - P.354-382.

Nicolarakis K.E., Almeida O.F., Yassouridis A., Herz A. Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release // Neurosci. - 1989. - V.31. - N.73. - P.269-273.

North R.A., Williams J.T. How do opiates inhibit neurotransmitter release //Trends. Neurosci. - 1983. - V.6. - N.8. - P.337-339.

Oehme P. Substance P: Regulatory functions // Wiss. Beitz. M.-luther Univ. Hall-Wittenberg P.- 1988.- 32.- P. 179-190

Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates 1985 // Peptides. - 1986. - V.7. - N.5. P.907-933.

Patterson T.A., Schulteins G., Alvarado M.C., Martinez J.L.-J.R., Bennet E.L., Rossenzweig M.R., Hruby V.Y. Influence of opioid peptides on learningand memory process in the chick // Behav.-Neurosci.-1989.-Apr.-103, №2.- P.429-437

Przewlocki R. et.al. Gene expression and lokalization of opioid peptides in immune cells of inflamed tissue: functional role in antinoception // Neurosci.-1992.-48, №2.- P.491-500

Rakudi H., Yu H., Kamitani A., Nakamura Y., Ohishi M., Kamide K., Nakata Y., Takami S., Higaki J., Ogihara T. Links between hypertension and myocardial infarction // Am. Heart. J. - 1996, Jul. - V.132. - N.1. - P.213-221.

Rodrigues C., Brayton K.A., Brownstein M., Dixon J.E. Rat preprocarboxypeptidase H: cloning, characterisation and sequence of the cDNA and regulation of the mRNA by corticotropin-releasing factor // J. Biol.Chem. -1989.- v.264.-P.5988-5995

Rossier J., Battenberg E., Piffman Q. et al. Hypothalamic enkephalin neurons may regulate the neurohypophysis // Nature. - 1979. - V.277. - P.653-655.

Roth W.W., Mackin R.B., Spiess J., Goodman R.H., Noe B.D. Primary structure and tissue distribution of angelerfish carboxypeptidase H // Mol. Cell Endocrinol. - 1991. - V.78. - N.3. - P.171-178.

Rothman R.B., Bycov V., Xue B.G., Xu H., De-Costa B.R., Jacobson A.E., Rice K.C., Kleinman J.E., Brady L.S. Interaction of opioid peptides and other drugs with miltiple kappa receptors in rat and human brain / Evidence for species differences //Peptides. - 1992, Sep.-Oct. - V.13. - N.5. - P.977-987.

Ryoichi K., Reiko S., Takshi K. et.al. Hydrolysis of neo-kyotophin (Thr-Ser-Lys-Tyr-Arg) and [met]enkephalin - Arg₆-Phe₇ by ACE from moncey brain // Biochem. Pharmakol.-1986.-35, №24.- P.4499-4503

Schmieder R.E., Schobel H.P., Gatzka C.E., Hauser W., Dominik P., Mann J.F., Luft F.C. Effects of angiotensin converting enzyme inhibitor on renal heamodynamics during mental stress // J. Hypertens. - 1996, Oct. - V.14. - N.10. - P.1201-1207.

Seredenin S.B., Blednov Y u A., Badysktov B.A. Pharmacogenetic analyses of mechanisms of emotional stress: effects of benzodiazepines // Ann. Inst. Super. Sanitc. - 1990. - V.26. - P.81.

Simantov R., Showman A.M., Synder S.V. A morphine - like factor enkephalin in rat brain subcellular localization // Brain Res. - 1976. - V.107. - P.650-657.

Simon E.J. Opioid receptors and Endogenous opioid peptides // Med. Res. Rev. - 1991. - V.11. - N.4. - P.357-374.

Skeggs L.T., Jr.Kahn J.R., Shumway N.P. The preparatia and function of hypertensin cпnverting enzyme // J. Exp. Med. - 1956. - V.103. - P.295.

Skidgel R.A. Basic carboxypeptidases: regulators of peptide hormone activity //Trends Pharmacol. Sci. - 1988. - V.9. - N.8. - P.299-304.

Skidgel R.A., Jonson A.R., Evda E.G. Hydrolisys of opioid hexapeptides by carboxypeptidase N. Presenc of carboxypeptidase in cell membranes // Biochem. Pharmacol. - 1984. - V.33. - N.21. - P.3471-3478.

Snyder S.H. Brain peptides as neurotransmitters // Science. - 1980. - V.209. - P.976-983.

Soffer R.L., Ei-Dorry H.A. Angiotensin-converting enzyme: immunological, structural and developmental aspects // Federation Proc.-1983.-P.2735-2739

Stanisz A.M., Scicchitano R., Payan D., Bienestock J. In vitro studies of immunoregulation by substance P and somatostatin / Second Intern. Workshop on NIM: Scientific Programme and Abstracts. - Dubrobnik, 1986. - P.37.

Stein E.A., Hiller J.M., Simon E.R. Effect of stress on opioid receptor binding in the rat central nervous system // Neurosci. - 1992, Dec. - V.51. - N.3. - P.683-690.

Steiner D.F. The biosynthesis of biologically active peptides: a perspective / Peptide Biosynthesia and processing /Frisker L.D. (eds.). - CRC Press. - Boca Ration. - Florida, 191. - P.1-16.

Strittmater S.M., Lynch D.R., Snyder S.H. (³H)guanidinoethyl merkaptosuccinic acid binding to tissue homogenates selective labeling of enkephalin convertase // J. Biol. Chem.- 1984.- 259, №19.- P.11812-11817

Supattapone S., Frisker L.D., Snyder S.H. Purification and characterization of membranebound enkephalin-forming carboxypeptidase “enkephalin convertase” // J. Neurochem. - 1984. - V.42. - N.4. - P.1017-1023.

Taub D.D., Eisenstein T.K., Geller E.B., Adler M.W., Rogers T.J. Immunomodulatory activity of mu - and Rappa-selective opioid agonists // Proc. Natl. Acad. Sci. USA. - 1991, Jan., 15. - V.88. - N.2.

Terenius L. Opioid peptides, pain and stress // Prog. Brain Res. - 1992.- 92.-P. 375-383

Tezapsidis N., Parish D.C. Characterizatoin and partial purificatoin of a novel prohormone processing enzyme from bovine adrenal medulla // FEBS Lett.-1989.-246, №1.-P. 44-48

Turner A.I. Neuropeptide processing enzymes // Trends. Neurosci.- 1984.-7, №7.- P.258-260

Van-Giersbergen P.L., Cox-Van-Put J., De-Jong W. Central and peripheral opiate receptors appear to be activated during controlled haemorrhagic hypotension // J. Hypertens. Suppl. - 1989, Dec. - V.7. - N.6. - P.26-27.

Vernicos-Danellis J., Heyback J.P. Psychophysiologic mechanismus regulating the hypothalamic-pituitary-adrenortical response to stress / Selyes guide to stress research /Eds. Selye H. - New York: Van Nostrand Reinhold Co., 1980. - P.206-251.

Viel E., Lefrant J.Y., Aya G., Eledjam J.J. Opioids by the perimedullary route: mechanisms of opioid analgesia // Cah. Anesthesiol. - 1991. - V.39. - N.1.

White J.D., Gall C.M. Proenkephalin is prozessed in a projectionspecific monner in the rat central nervous system // Proc. Nat. Acad. Sci. USA. Biol. Sci.-1986.- 83, №18.- P. 7099-7103

Yukimura T., Under T., Rascher W. Central peptidergic stimulation in blood pressure control: role of enkephalins in rats // Clin. Sci.-1981.-61, №7.-P.3475-3505

ПРИЛОЖЕНИЕ

Таблица 1. Активность КПН, ФМСФ-ингибируемой КП и АПФ у интактных животных (нмоль продукта, образовавшегося за 1 мин инкубации на 1 мг белка, М m, n = 5-6, здесь и в таблицах 2-7: Г - гипофиз, СМ - средний мозг, ГТ - гипоталамус, ГК - гиппокамп, СТ - стриатум, БП - большие полушария, НП - надпочечники, СЕ - семенники)

Таблица 2. Активность КПН, ФМСФ-ингибируемой КП и АПФ в мозге и тканях крыс при воздействии острого ЭБС (нМ продукта, образовавшегося за 1 мин инкубации на 1 мг белка, М±m, n=5, *- p<0,05, **- p<0,01, ***- p<0,001 к норме, здесь и в таблицах 3-7: I - отдел мозга, орган, II - время после начала воздействия)

Таблица 3. Активность КПН, ФМСФ-ингибируемой КП и АПФ в мозге и тканях крыс при введении лей-энкефалин-арг (нМ продукта, образовавшегося за 1 мин инкубации на 1 мг белка, М±m, n=5, звездочками показана достоверность: *- p<0,05, **- p<0,01, ***- p<0,001 к норме)

Таблица 4. Влияние лей-энкефалин-арг на активность КПН, ФМСФ-ингибируемой КП и АПФ in vitro (в % от контроля, контроль 100%)

Таблица 5. Активность КПН при введении лей-энкефалин-арг на фоне острого ЭБС (*- p<0,05, **- p<0,01, ***- p<0,001).

Таблица 6. Активность ФМСФ-ингибируемой КП при введении лей-энкефалин-арг на фоне острого ЭБС (*- p<0,05, **- p<0,01, ***- p<0,001).

Таблица 7. Активность АПФ при введении лей-энкефалин-арг на фоне острого ЭБС (*- p<0,05, **- p<0,01, ***- p<0,001 ).